Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer

Showing 15 posts of 894 posts found.

iPhone

Pfizer launches iPhone service for doctors

June 3, 2010
Medical Communications Apple, Epocrates, Pfizer, digital doctors, emedicine, iphone

A new service to allow doctors to communicate with Pfizer via iPhones and other mobile devices has been unveiled. Clinicians …

News

Inspra performs strongly in heart failure patients

May 28, 2010
Research and Development, Sales and Marketing Inspra, Pfizer, chronic heart failure, heart failure

Pfizer is to end a clinical trial of Inspra early because of signs that it significantly cuts the risk of …

News

Pfizer R&D head exits for AstraZeneca

May 27, 2010
Research and Development AstraZeneca, Pfizer, appointment, research and development

One of Pfizer’s two heads of research and development Martin Mackay is to leave the company for rivals AstraZeneca. Only …

News

Pfizer takes the axe to manufacturing operations

May 19, 2010
Manufacturing and Production Pfizer, job cuts, manufacturing

Pfizer is to reduce manufacturing staffing by around 6,000 – around 18% of its total production workforce – and close …

News

Pfizer signs ground-breaking academic research deal

May 18, 2010
Research and Development Pfizer, US, academia, clinical research

Pfizer is teaming up with academia in a five-year bid to discover new uses for existing compounds. The pharma manufacturer …

News

Pfizer adds another product to its PAH franchise

May 14, 2010
Research and Development Ergonex, PAH, Pfizer, Thelin, revatio, terguride, viagra

Pfizer has signed an agreement to acquire terguride, a drug for pulmonary arterial hypertension (PAH) currently in phase II testing, …

News

Pfizer to cut jobs in New York

May 11, 2010
Sales and Marketing Pfizer, job cuts

Pfizer is reportedly planning to cut or relocate up to 1,400 jobs in New York in its on-going restructuring programme. …

News

Pfizer and Merck post modest results

May 6, 2010
Sales and Marketing 2010 financials, Merck, Pfizer

The acquisition of Wyeth has added over $5 billion to Pfizer’s revenue buts its own sales fail to shine.  Both …

News

Pfizer still at number 1, but Lipitor to slip

May 4, 2010
Sales and Marketing Humira, Lipitor, Pfizer, sales

New research suggests that the pharma world is going to be shaken up over the next few years – although …

News
Pfizer payments

Pfizer first to disclose trial payments

April 1, 2010
Research and Development, Sales and Marketing Pfizer, industry reputation, payments

Pfizer has disclosed in full the payments it has made to US doctors to conduct clinical trials and to promote …

News

Pfizer suffers late-stage cancer drug failures

March 12, 2010
Research and Development Cancer, Pfizer, Sutent, figitumumab

Pfizer has suffered late-stage trial failures for Sutent and lung cancer candidate figitumumab. Kidney cancer drug Sutent (sunitinib) failed to …

News
Ratiopharm HQ

Pfizer muscles in on Ratiopharm sale

March 11, 2010
Sales and Marketing Pfizer, Ratiopharm, Teva, generics

Pfizer has reportedly bid $4 billion for German generics firm Ratiopharm in a bid to rapidly expands its portfolio in …

News

Pfizer and King’s to collaborate on pain research

March 9, 2010
Research and Development King's, Pfizer, UK

Pfizer has partnered with King’s College London to create an open innovation laboratory for pain research.The project will include a …

News
Pfizer Facebook

Digital Pharma: Byte-sized roundup

March 8, 2010
Medical Communications Pfizer, digital pharma, digital pharma pfizer

A roundup of digital developments, including Pfizer’s new Facebook page and beta-phase science blog, Lundbeck, BMS, Baxter and Janssen-Cilag on …

News
Blood clot

Phase III success for apixaban

March 5, 2010
Research and Development BMS, Pfizer, VTE, apixaban

Pfizer and Bristol-Myers Squibb’s apixaban has shown promising results in a late-stage head-to-head trial with Sanofi-Aventis’ Lovenox. The oral anti-coagulant …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026